Keywords: b-ms, baraclude, available, uk, drugmaker, bristol-myers, squibb

B-MS's Baraclude available in UK

Article | 25 September 2006

US drugmaker Bristol-Myers Squibb says that its antiviral Baraclude (entercavir), approved for the treatment of chronic hepatitis B infection, is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Baraclude

Entecavir

Go to drug listing